Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case–control studies

S Dial, K Alrasadi, C Manoukian, A Huang, D Menzies - Cmaj, 2004 - Can Med Assoc
Background: Antibiotic disruption of the normal intestinal flora is a well-known risk factor for
Clostridium difficile-associated diarrhea. Reduced gastric acidity has been suggested as a …

Aortic calcifications in familial hypercholesterolemia: potential role of the low-density lipoprotein receptor gene

K Alrasadi, K Alwaili, Z Awan, D Valenti, P Couture… - American Heart …, 2009 - Elsevier
BACKGROUND: We have previously reported premature, extensive aortic calcifications in
patients with homozygous familial hypercholesterolemia (hmzFH) due to mutations in the low-…

Functional mutations of the ABCA1 gene in subjects of French–Canadian descent with HDL deficiency

K Alrasadi, IL Ruel, M Marcil, J Genest - Atherosclerosis, 2006 - Elsevier
Mutations in the ABCA1 gene cause defective cellular lipid efflux and severe familial HDL
deficiency. We examined the prevalence of mutations at the ABCA1 gene in 58 unrelated …

Approach to the diagnosis and management of lipoprotein disorders

K Alwaili, K Alrasadi, Z Awan… - Current opinion in …, 2009 - journals.lww.com
Approach to the diagnosis and management of lipoprotein diso... : Current Opinion in
Endocrinology, Diabetes and Obesity Approach to the diagnosis and management of …

Effect of ABCA1 mutations on risk for myocardial infarction

I Iatan, K Alrasadi, I Ruel, K Alwaili, J Genest - Current atherosclerosis …, 2008 - Springer
The adenosine triphosphate-binding cassette A1 (ABCA1) gene codes for a cellular
phospholipid and cholesterol transporter that mediates the initial and essential step in high-density …

Comparison of treatment of severe high-density lipoprotein cholesterol deficiency in men with daily atorvastatin (20 mg) versus fenofibrate (200 mg) versus extended …

K Alrasadi, Z Awan, K Alwaili, I Ruel, A Hafiane… - The American journal of …, 2008 - Elsevier
To determine whether available lipid-modifying medication can increase high-density lipoprotein
(HDL) cholesterol in well-defined genetic or familial HDL-deficiency states, we studied …

[PDF][PDF] Physical fitness attributes, vitamin D, depression, and BMD in Omani's children

…, H Bererhi, R Shukri, K Alrasadi - European Scientific …, 2013 - researchgate.net
Physical fitness attributes, vitamin D, depression, and BMD in Omani’s Children 9-12 years
old were investigated in 54 girls and 42 boys (average age of 12.9±1.6) to assess health …

The Gulf Achievement of Cholesterol Targets in Out-Patients Study (GULF ACTION): Design, Rationale, and Preliminary Results

…, MA Jarallah, MI Amin, K Alrasadi… - Current vascular …, 2023 - ingentaconnect.com
Aim: To assess the current dyslipidemia management in the Arabian Gulf region by describing
the demographics, study design, and preliminary results of out-patients who achieved low-…

Treatment of low high-density lipoprotein cholesterol

Z Awan, KA Waili, K Alrasadi, J Genest - Canadian Journal of Cardiology, 2008 - Elsevier
The prevention of atherosclerotic vascular disease has changed considerably with the
recognition that modifying cardiovascular risk factors (smoking, obesity, physical inactivity, …

[HTML][HTML] In silico design of novel anticoagulant peptides targeting blood coagulation factor VIIa

MSQ Al-Amri, K Alrasadi, R Bayoumi… - Sultan Qaboos …, 2011 - ncbi.nlm.nih.gov
Objectives: The coagulation cascade initiated during vascular injury prevents bleeding.
Unwanted clot formation is however detrimental and requires the use of anticoagulants for …